The authors, Eliezer Yudkowsky and Nate Soares, mean that very literally: a superintelligence — an AI that’s smarter than any ...

UCB, a global biopharmaceutical company, today announced three-year data from the BE HEARD trials for BIMZELX® (bimekizumab-bkzx) in adults with moderate-to-severe hidradenitis suppurativa (HS).